Keyphrases
Transplantation
100%
Hepatitis C Virus Recurrence
100%
Direct Antivirals
100%
Switchback
100%
Hepatitis C Virus
80%
Ribavirin
60%
Interferon-α (IFN-α)
40%
Protease Inhibitors
40%
Cell Surface
20%
Immunoglobulin
20%
Renal Disease
20%
Double Therapy
20%
Triple Therapy
20%
Liver Transplantation
20%
Antiviral Drugs
20%
Recurrence Risk
20%
Cyclosporine
20%
Pretransplant
20%
Safe Use
20%
AIDS/HIV
20%
Drug Class
20%
Dose Adjustment
20%
Tolerability
20%
Tacrolimus
20%
Mouse Model
20%
Drug Interactions
20%
Small Molecules
20%
Virus Receptor
20%
Virus Cell Entry
20%
Graft Infection
20%
Direct-acting Antiviral Drugs
20%
Hepatitis C Virus Inhibitors
20%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
100%
Hepatitis C Virus
100%
Antiviral Drug
100%
Proteinase Inhibitor
42%
Ribavirin
42%
Interferon
28%
Immunoglobulin
14%
Human Immunodeficiency Virus Proteinase
14%
Ciclosporin
14%
Tolerability
14%
Mouse Model
14%
Tacrolimus
14%
Drug-Drug Interaction
14%
Graft Infection
14%
Virus Receptor
14%
Medicine and Dentistry
Hepatitis C Virus
100%
Recurrent Disease
100%
Antiviral Drug
100%
Proteinase Inhibitor
42%
Ribavirin
42%
Interferon
28%
Cell Surface
14%
Liver Transplantation
14%
Immunoglobulin
14%
Tacrolimus
14%
Cyclosporine
14%
Drug Interaction
14%
Graft Infection
14%
Virus Receptor
14%
HIV-1 Protease
14%
Immunology and Microbiology
Hepatitis C Virus
100%
Ribavirin
42%
interferon
28%
Cell Surface
14%
Intravenous Immunoglobulin
14%
Mouse Model
14%
Human Immunodeficiency Virus
14%
Liver Transplantation
14%
Ciclosporin
14%
Tacrolimus
14%
Drug-Drug Interaction
14%